Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetic industries, has started operations at a new plant in Zhenjiang Dagang, China, for the production of glass primary pharmaceutical packaging.
After approximately four years of construction, a state-of-the-art, energy-efficient building covering around 40,000 m2 (60 mu) has been completed in the Zhenjiang Economic Development Zone in Jiangsu Province, fully meeting the stringent regulatory requirements of the pharmaceutical and biotech industries.
An additional 33,000 m2 (50 mu) of land is available for future expansion. The new plant also sets new standards in terms of sustainability. With this new facility, Gerresheimer is doubling its production capacity for primary packaging for injectable pharmaceuticals in China.
Gerresheimer currently produces pharmaceutical vials and ampoules at the site - primarily for the Chinese market - with a workforce of about 250 employees; approximately 50 new jobs are expected to be created in the coming years. With its fourth Tubular Glass plant in China, Gerresheimer is continuing its successful 20-year partnership with Shuangfeng Glass.
The start of operations of the new plant in Zhenjiang Dagang also marks the 20th anniversary of the successful partnership between the Gerresheimer Group and the Chinese company Shuangfeng Glass. The joint venture Gerresheimer Shuangfeng Pharmaceutical Glass now operates a total of four Tubular Glass plants in China: two plants in Danyang, one plant in Zhenjiang, and the new plant in Zhenjiang Dagang.
